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Background
This report is a summary of Deviceassociated (DA) Module data collected by hospitals participating in the National Healthcare Safety Network (NHSN) for events occurring from January through December 2010 and reported to the Centers for Disease Control and Prevention (CDC) by July 7, 2011 . This report updates previously published DA Module data from NHSN and provides contemporary comparative rates. 1 This report complements other NHSN reports, including national and state-specific reports of standardized infection ratios (SIRs) for select healthcare-associated infections (HAIs). 2, 3, 4 NHSN was established in 2005 to integrate and supersede three legacy surveillance systems at CDC: the National Nosocomial Infections Surveillance system, the Dialysis Surveillance Network, and the National Surveillance System for Healthcare Workers. NHSN data collection, reporting, and analysis are organized into three components: Patient Safety, Healthcare Personnel Safety, and Biovigilance, and use standardized methods and definitions in accordance with specific module protocols. 5, 6, 7 Institutions may use modules singly or simultaneously, but once selected, they must be used for a minimum of one calendar month. All infections are categorized using standard CDC definitions that include laboratory and clinical criteria. 7 The DA Module may be used by facilities other than hospitals, including outpatient dialysis centers. A report of data from this module for outpatient dialysis centers was published separately. 8 NHSN facilities contributing HAI surveillance data to this report did so voluntarily or in response to state mandatory reporting requirements. CDC aggregated these data into a single national database for the stated purposes in place in 2010, which were to:
• Collect data from a sample of healthcare facilities in the United States to permit valid estimation of the magnitude of adverse events among patients and healthcare personnel.
• Collect data from a sample of healthcare facilities in the United States to permit valid estimation of the adherence to practices known to be associated with prevention of these adverse events.
• Analyze and report collected data to permit recognition of trends.
• Provide facilities with risk-adjusted metrics that can be used for inter-facility comparisons and local quality improvement activities.
• Assist facilities in developing surveillance and analysis methods that permit timely recognition of patient and healthcare worker safety problems and prompt intervention with appropriate measures.
• Conduct collaborative research studies with NHSN member facilities (e.g., describe the epidemiology of emerging healthcare-associated infections [HAI] and pathogens, assess the importance of potential risk factors, further characterize HAI pathogens and their mechanisms of resistance, evaluate alternative surveillance and prevention strategies).
Patient-and facility-specific data reported to CDC are kept confidential in accordance with sections 304, 306, and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).
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Methods
Data Collection Methods
For reporting to the DA Module, healthcare facility personnel responsible for infection prevention and patient safety may choose, with consideration of state mandates and prevention initiatives, to collect data on central line-associated primary bloodstream infections (CLABSI), ventilator-associated pneumonias (VAPs), or urinary catheter-associated urinary tract infections (CAUTI) that occur in patients staying in a patient care location such as a critical or intensive care unit (ICU), specialty care area, or inpatient ward. In NHSN, these locations are further characterized according to patient population: adults, children, or neonates (in tables, pediatric and neonatal locations are so noted). In neonatal intensive care unit (NICU) locations (level III or level II/III), infection preventionists (IPs) collect data on central line-associated and umbilical catheter-associated BSI or VAP that occur in patients in each of five birth-weight categories (≤750 g, 751-1000 g, 1001 -1500 g, 1501 -2500 g, and >2500 g); data on CAUTI are not collected in any NICU location. Corresponding location-specific denominator data consisting of patient-days and specific device-days are also collected by IPs or other trained personnel.
In non-NICU locations, the devicedays consist of the total number of central line-days, urinary catheterdays, or ventilator-days. In NICU locations, the device-days consist of the total number of central line-days and umbilical catheter-days, or ventilatordays for each birth-weight category.
Data Analysis Methods
DA data reported in 2010 were compared to data published in the last report to determine if there were consistent, statistically significant differences in pooled mean rates, medians, and percentile distributions. 1 Eight new locations -prenatal critical care, pediatric step-down (post critical care), antenatal care ward, burn ward, jail ward, pediatric surgical ward, telemetry ward, and pediatric bone marrow transplant specialty care area -had sufficient data to be included in this report.
Locations were further stratified by unit bed size and/or major teaching status to determine if pooled mean rates, medians, and empirical distributions significantly differed between two groups for all DA infections. Comparisons of pooled mean rates were performed using Poisson regression. These comparisons could be influenced by potential outlier rates from locations with disproportionately large denominators. Therefore, greater weight was given to the results of nonparametric tests comparing the medians for location shift and empirical distributions for assessing differences across the range of reported rates. These nonparametric comparisons by definition require no validity assumptions and provide test results that are not subject to the potential weighting influence of high or low rates with large denominators. Comparisons of the median and percentile distribution were made if there were at least 50 locations contributing to one or more strata and at least 20 locations contributing to the percentile distribution in both strata. The data for adult combined medical/surgical ICUs were split into two groups by type of hospital: "major teaching" and "all others." Facilities selfidentified teaching status through an annual facility survey. Major teaching status was defined as a hospital that is an important part of the medical school teaching program in which the majority of medical students rotate through multiple clinical services. The "all others" group of adult combined medical/surgical ICUs were further split into two groups by unit bed size: "≤15 beds" and "> 15 beds." The data for adult medical ICUs were split into two groups by type of hospital as defined above. In addition, we assessed the potential impact of hospital type as defined above, on DA infection rates and distributions for additional critical care and inpatient ward locations, including surgical ICUs, surgical cardiothoracic ICUs, step-down units, medical wards, and medical/surgical wards.
Device utilization (DU) of a location is one measure of invasive practices in that location and constitutes an extrinsic risk factor for healthcareassociated infection.
9 DU may also serve as a marker for severity of illness of patients, that is, patients' intrinsic susceptibility to infection. DU is measured as a ratio of device days to patient days for each location type.
The pooled mean DA infection rates and DU ratios required data from at least 5 different reporting units of a given location type. For the percentile distributions, data from at least 20 different locations were required, excluding rates or DU ratios for locations that did not report at least 50 devicedays or patient-days. We increased the minimum number of device days or patient days to 100 days and assessed whether the distribution of the DA rates and DU ratios changed significantly. This increase did not have an impact on the percentile distributions and therefore, the minimum number of days remained at 50 days in order to maintain consistency with previous reports. Because of this, the number of locations contributing data may vary among the tables.
Results
Among the 4122 facilities eligible to report to NHSN at the end of 2010, 3029 filed monthly reporting plans signaling their intent to follow the DA module for at least one month and 2473 hospitals reported at least DA denominator data for some patient cohorts under surveillance during 2010. These 2473 hospitals were located in 49 states and the District of Columbia and were predominantly general acute care hospitals (Table   1) ; approximately two-thirds were smaller hospitals of 200 beds or less (63.1%), and only 12.5% were categorized as major teaching facilities ( 
Discussion
This report summarizes the HAI data reported to the DA module of NHSN during 2010. The data in this report were restricted to a single year for several reasons. First, there were more facilities contributing data than in previous years and because of this, there were sufficient data reported in 2010 to support the analysis of a single year of data (e.g., considerable data contributing to the pooled means, most location types with >20 locations reporting), thus obviating the need to combine data with previous years. Second, CAUTI data included in this report can be used to evaluate progress toward infection prevention goals established in the U. S. Department of Health and Human Services' HAI Action Plan. 1, 10 Third, analyzing one year of data removes the need to assess the influence mandatory HAI reporting and resultant increase of new reporters may have on the aggregate data across several years. Finally, by restricting data to a single year, decreases in HAI rates are more apparent and can highlight continued prevention efforts in different patient care areas. This strategy also fulfills the need for more timely publication of comparative rates.
The characteristics of hospitals reporting to NHSN remain consistent with the last published report, including a sustained contribution of smaller hospitals. 1 The diversity of healthcare facilities reporting to NHSN may change in future reports as a result of two factors: 1) increased use of NHSN as the operational system to fulfill mandatory HAI reporting requirements in additional states, and 2) the Comparisons of these data to the previous NHSN Annual Report reveal several differences. Reporting of DA infections from inpatient wards continues to increase, which is apparent in the 85% increase in the number of both medical wards and medical/surgical wards reporting CLABSI rates. 1 The increase in the volume of DA data in this report has allowed for the inclusion of new ICU and ward locations, as well as the publication of percentile distributions for previously reported, yet low volume, location types. Of particular note is the new location, telemetry ward, in which 144 locations contributed to the CLABSI pooled mean and of those, 142 contributed to the percentile distribution.
Extensive analyses of hospital type on all DA rates were performed for 15 different types of ICU and ward locations, where data in each strata were sufficient. Hospital type continues to be a significant factor for all three DA rates and percentile distributions in medical ICUs. Additionally, hospital type and bed size both continue to be significant factors in DA rates for medical/surgical ICUs. Note that while the CLABSI rates for medical/surgical "all other" ICUs appear to be similar, the percentile distributions were shown to be significantly different as a result of nonparametric statistical tests. Therefore, this type of stratification in medical/surgical ICUs was sustained. Through these analyses, hospital type was found to be a significant factor in surgical ICUs across all DA infections and measures. Other locations were not further stratified by hospital type, as the conclusions of the statistical tests were either not consistent across DA infections or the volume in comparative strata was too diverse. Further growth in NHSN's coverage, specifically in the number and types of inpatient wards and specialty care areas reporting data, will improve NHSN usefulness in characterizing rates of DA infections among patients in those care areas.
Another important difference in results of this report compared to those in previous reports is the combination of line types in the calculation of CLABSI rates and DU ratios for select locations. In an effort to reduce data collection burden, the NHSN protocols will be adjusted in 2012 such that the distinction of central-line type in NICU (umbilical vs. non-umbilical) and long term-acute care (LTAC) (temporary vs. permanent) locations will no longer be required. Therefore, the CLABSI rates and DU ratios for NICU and LTAC locations were inclusive of both line types in each location.
Tables 11-18 were included to aid the reader in interpreting the DA infection rates data. One important use of these data is to better understand the distribution of DA infections by type of reporting criteria. For example, nearly 81% of the CLABSIs from adult and pediatric ICU and inpatient wards were identified using the least subjective criterion (1); however, for NICUs, approximately two-thirds used this criterion. Similarly, the specific type of ventilator-associated pneumonia (VAP) most frequently reported, regardless of location, was the clinical criterion (PNU1). However, in adult and pediatric critical care locations, approximately 42% of VAPs that were reported used more rigorous criteria that include laboratory findings (PNU2 and PNU3) whereas in NICU locations, only 17% of VAPs were reported using these same criteria.
As more and diverse types of facilities participate in NHSN either voluntarily or by mandate, the need for careful scrutiny of the data increases. We will continue to assess how the changing composition of facilities and the changing proportion of data contributed by various types of facilities impact the rates and their distributions so that the best possible risk-adjusted comparative data may be provided in future reports.
The data published in this report will be available to NHSN users for comparisons within the NHSN application early in 2012. For those that do not report to NHSN but would like to use these data for comparison, the information must first be collected from your hospital in accordance with the methods described for NHSN. 5, 6, 7 Refer to Appendices A and B for further instructions. Appendix A discusses the calculation of infection rates and DU ratios for the DA Module. Appendix B gives a step-by-step method for interpretation of percentiles of infection rates or DU ratios. Although a high rate or ratio (>90th percentile) does not necessarily define a problem, it does suggest an area for further investigation. Similarly, a low rate or ratio (<10th percentile) may be the result of inadequate infection detection.
Facilities should use the data in this report and their own data to guide local prevention strategies and other quality improvement efforts to reduce the occurrence of infections as much as possible.
The authors are indebted to the NHSN participants for their ongoing efforts to monitor infections and improve patient safety. We also gratefully acknowledge our colleagues in the Division of Healthcare Quality Promotion who tirelessly support this unique public health network.
The findings and conclusions of the report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. 
Major:
Hospital is an important part of the teaching program of a medical school and the majority of medical students rotate through multiple clinical services.
Graduate:
Hospital is used by the medical school for graduate training programs only; i.e., residency and/or fellowships.
Limited:
Hospital is used in the medical school's teaching program only to a limited extent. + The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥ 50 device days for rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile distributions are not calculated. ‡ Includes free-standing long-term acute care hospitals and long-term acute care locations within the general acute care hospital setting.
¥ Includes inpatient long term care locations within the general acute care hospital setting. 
